Modern antiplatelet agents in coronary artery disease.

Expert review of cardiovascular therapy

Volumn 10, Issue 10, 2012, Pages 1261-1272

  Power, Rachel F ^a   Hynes, Brian G ^b   Moran, Darragh ^b   Yagoub, Hatim ^b   Kiernan, Gary ^b   Ruggiero, Nicholas J ^b   Kiernan, Thomas J ^b  

^a Department of Medicine National University of Ireland Cork   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; PROTEINASE ACTIVATED RECEPTOR 1; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR;

ANIMAL; CORONARY ARTERY DISEASE; DRUG ANTAGONISM; DRUG COMBINATION; DRUG DESIGN; DRUG EFFECT; HUMAN; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; REVIEW;

ANIMALS; CORONARY ARTERY DISEASE; DRUG DESIGN; DRUG THERAPY, COMBINATION; HUMANS; INDIVIDUALIZED MEDICINE; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTOR, PAR-1; RECEPTORS, PURINERGIC P2Y12;

EID: 84877151718     PISSN: None     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.12.127     Document Type: Review

References (0)